GRI Bio, Inc.
GRI
$1.61
$0.04522.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.39% | -40.38% | -45.23% | -50.79% | -40.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 100.00% | -- |
| Total Operating Expenses | 19.90% | -22.02% | -26.05% | -22.92% | -4.65% |
| Operating Income | -19.90% | 22.02% | 26.05% | 22.92% | 4.65% |
| Income Before Tax | -67.53% | -3.54% | 7.44% | 37.87% | 28.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -67.53% | -3.54% | 7.44% | 37.87% | 28.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.53% | -3.54% | 7.44% | 37.87% | 28.12% |
| EBIT | -19.90% | 22.02% | 26.05% | 22.92% | 4.65% |
| EBITDA | -19.91% | 22.03% | 26.06% | 22.93% | 4.65% |
| EPS Basic | 93.42% | 81.03% | 61.74% | 41.18% | -0.45% |
| Normalized Basic EPS | 86.20% | 17.87% | -- | -- | -- |
| EPS Diluted | 91.46% | 79.32% | 60.09% | 41.18% | -0.45% |
| Normalized Diluted EPS | 86.20% | 17.87% | -- | -- | -- |
| Average Basic Shares Outstanding | 6,084.03% | 6,524.06% | -- | -- | -- |
| Average Diluted Shares Outstanding | 3,632.09% | 1,596.85% | 911.05% | 268.56% | 34.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |